1. Home
  2. AGPU vs LNSR Comparison

AGPU vs LNSR Comparison

Compare AGPU & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Axe Compute Inc. Common Stock

AGPU

Axe Compute Inc. Common Stock

BUY

Current Price

$7.87

Market Cap

83.5M

Sector

N/A

ML Signal

BUY

Logo LENSAR Inc.

LNSR

LENSAR Inc.

HOLD

Current Price

$6.06

Market Cap

75.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGPU
LNSR
Founded
2002
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Electronics
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.5M
75.1M
IPO Year
2008
2005

Fundamental Metrics

Financial Performance
Metric
AGPU
LNSR
Price
$7.87
$6.06
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $11.33
AVG Volume (30 Days)
★ 281.5K
40.8K
Earning Date
11-13-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.61
Revenue
$125,284.00
★ $58,435,000.00
Revenue This Year
$48,110.47
$4.90
Revenue Next Year
$614.07
$18.71
P/E Ratio
★ N/A
$9.90
Revenue Growth
N/A
★ 9.24
52 Week Low
$1.03
$4.95
52 Week High
$13.49
$12.94

Technical Indicators

Market Signals
Indicator
AGPU
LNSR
Relative Strength Index (RSI) 34.74 36.83
Support Level $7.44 $5.34
Resistance Level $9.30 $6.20
Average True Range (ATR) 0.91 0.20
MACD -0.35 -0.00
Stochastic Oscillator 6.96 29.46

Price Performance

Historical Comparison
AGPU
LNSR

About AGPU Axe Compute Inc. Common Stock

Axe Compute Inc functions as an active infrastructure operator. The company intends to expand access to AI compute resources by utilizing the Aethir network, which provides scalable, cost-efficient cloud GPU services for AI, machine learning, gaming, and rendering applications. Through the use of Aethir's decentralized international infrastructure, the company aims to provide access to bare-metal GPUs at scale for both emerging and established organizations.

About LNSR LENSAR Inc.

LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.

Share on Social Networks: